Авторы

  • Khudaykulova V.D.
  • Kenjaev M.L.

Ключевые слова:

MMP-9, development of chronic heart failure, frequency of gene polymorphism.

Библиографические ссылки

Asadov ZX, Yakubov UK Early diagnostics dysfunction myocardium he/she sick IBS c ispolzovaniem Speckle-tracking echocardiography. // Vestnik cardiology Uzbekistan. – 2021. – No. 4. - P. 33-38.

Bokeria LA, Mazur NA Chronic heart failure. - M.: Izdvo Binom, 2021. - 432 p.

Braunwald E. Heart Disease: A Textbook of Cardiovascular Medicine. - 11th ed. – Philadelphia: Elsevier, 2018. – 2060 p.

Casper DL, Fauci AS Harrison's Principles of Internal Medicine. - 21st ed. – New York: McGraw-Hill, 2022. – Vol. 1–2. - 4300 p.

Chair, SY, Wong, TKS, & Cheng, HY (2021). Non-coding RNAs as biomarkers and therapeutic targets for heart failure. Journal of Clinical Medicine, 10(4), 855. DOI: https://doi.org/ 10.3390/jcm10040855.

Fan, Y., Zhang, H., & Zhao, X. (2022). Multi-omics analysis identifies potential biomarkers and therapeutic targets in heart failure. BMC Genomics, 23(1), 741. DOI: https://doi.org/ 10.1186/s12864-022-08971-0

Gheorghiade M., Bonow RO Chronic heart failure in ischemic heart disease. // J Am Coll Cardiol. - 2017. - Vol. 70(4). – P. 470–483.

Januzzi JL et al. Natriuretic Peptides in Heart Failure: Biochemistry, Physiology and Clinical Use. // Eur Heart J. – 2020. – Vol. 41. – P. 1900–1908.

Lang RM et al. Recommendations for Cardiac Chamber Quantification by Echo-cardiography. // J Am Soc Echocardiogr. - 2015. - Vol. 28. – P. 1–39.

McDonagh TA et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. // European Heart Journal. - 2021. - Vol. 42(36). – P. 3599–3726.

Ridker PM, Libby P. Inflammation in Atherosclerosis: From Pathophysiology to Practice. // J Am Coll Cardiol. - 2021. - Vol. 78. – P. 1938–1956.

Shlyakhto Ye.V., Lebedev DS, Kovalenko VN Ischemic disease of the heart and heart failure. - SPb.: Polytechnic, 2020. - 388 p.

Shrivastava, S., & Dhingra, S. (2020). Genetic and proteomic biomarkers in heart failure: A systematic review. Frontiers in Cardiovascular Medicine, 7, 585. DOI: https://doi.org/ 10.3389/fcvm.2020.00585

Trukhan D. I., Burdina A. V. Sovremennye aspects of diagnosis of cardiac insufficiency: the role of natriuretic peptides. // Cardiology. – 2019. – No. 2. - S. 58–63.

Tsutsui H., Tsuchihashi-Makaya M. Clinical characteristics and outcomes in patients with heart failure. // Circ J. – 2018. – Vol. 82. – P. 278–284.

Vilensky B. S. Cardiology: current management – M.: GEOTAR - Media, 2019. – 640 p.

Wasan, RS, & Benjamin, EJ (2021). The genetic basis of heart failure: Integrating omics and artificial intelligence. Nature Reviews Cardiology, 18(9), 643–656. DOI: https://doi.org/10.10 38/s41569-021-00530-2

Yancy CW et al. ACCF/AHA Guideline for the Management of Heart Failure. // Circulation. - 2017. - Vol. 136. – P. e137–e161.

Yermakova T. Ye., Belova I. V. Significance of markers of inflammation and diagnosis of cardiac insufficiency. // Russian Cardiology Journal. – 2020. – No. 5. - S. 24–29.

Yu, G., Liu, X., & Zhang, Y. (2023). Identification of immune-related hub genes in heart failure through bioinformatics approaches. Frontiers in Immunology, 14, 1098621. DOI: https://doi.org/10.3389/fimmu.2023.1098621

Zhao, Q., Chen, Y., & Liu, J. (2023). The role of β-adrenergic receptor polymorphisms and MMP-9 gene variants in cardiovascular diseases: A systematic review. Genes, 14(3), 635. DOI: https://doi.org/10.3390/genes14030635